Drugs / ASF1057
last change Jun 2008 re-read 3 minutes ago

ASF1057

Developed for
seborrheic dermatitis
Investigated by
Astion Pharma A/S

Trials 1

20082009201020112012201320142015201620172018201920202021202220232024202520262027
PhaseRegistry idDatesIndicationSponsorStatusOutcome
Phase 3 NCT00565279 Dec 2007 → May 2008 seborrheic dermatitis Astion Pharma A/S Completed No outcome recorded

Evidence & citations 2 cited values

Every value below carries the sentence it was read from. 1 source stands behind the page.

FieldValueCited text
Known as ASF1057 ClinicalTrials.gov intervention name — accepted as the source's own label NCT00565279 ↗
Route Topical “Twice daily, topical” NCT00565279 ↗